| UniProt ID | ETV4_HUMAN | |
|---|---|---|
| UniProt AC | P43268 | |
| Protein Name | ETS translocation variant 4 | |
| Gene Name | ETV4 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 484 | |
| Subcellular Localization | Nucleus. | |
| Protein Description | Transcriptional activator that binds to the enhancer of the adenovirus E1A gene; the core-binding sequence is 5'[AC]GGA[AT]GT-3'.. | |
| Protein Sequence | MERRMKAGYLDQQVPYTFSSKSPGNGSLREALIGPLGKLMDPGSLPPLDSEDLFQDLSHFQETWLAEAQVPDSDEQFVPDFHSENLAFHSPTTRIKKEPQSPRTDPALSCSRKPPLPYHHGEQCLYSSAYDPPRQIAIKSPAPGALGQSPLQPFPRAEQRNFLRSSGTSQPHPGHGYLGEHSSVFQQPLDICHSFTSQGGGREPLPAPYQHQLSEPCPPYPQQSFKQEYHDPLYEQAGQPAVDQGGVNGHRYPGAGVVIKQEQTDFAYDSDVTGCASMYLHTEGFSGPSPGDGAMGYGYEKPLRPFPDDVCVVPEKFEGDIKQEGVGAFREGPPYQRRGALQLWQFLVALLDDPTNAHFIAWTGRGMEFKLIEPEEVARLWGIQKNRPAMNYDKLSRSLRYYYEKGIMQKVAGERYVYKFVCEPEALFSLAFPDNQRPALKAEFDRPVSEEDTVPLSHLDESPAYLPELAGPAQPFGPKGGYSY | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 6 | Acetylation | --MERRMKAGYLDQQ --CCCCCCCCCCCCC | 36.53 | 21543453 | |
| 6 | Sumoylation | --MERRMKAGYLDQQ --CCCCCCCCCCCCC | 36.53 | 28112733 | |
| 16 | Phosphorylation | YLDQQVPYTFSSKSP CCCCCCCCEECCCCC | 22.89 | 23312004 | |
| 17 | Phosphorylation | LDQQVPYTFSSKSPG CCCCCCCEECCCCCC | 15.80 | 23312004 | |
| 19 | Phosphorylation | QQVPYTFSSKSPGNG CCCCCEECCCCCCCC | 29.11 | 23312004 | |
| 20 | Phosphorylation | QVPYTFSSKSPGNGS CCCCEECCCCCCCCC | 32.72 | 23312004 | |
| 21 | Acetylation | VPYTFSSKSPGNGSL CCCEECCCCCCCCCH | 60.51 | 21543453 | |
| 22 | Phosphorylation | PYTFSSKSPGNGSLR CCEECCCCCCCCCHH | 39.73 | 23312004 | |
| 27 | Phosphorylation | SKSPGNGSLREALIG CCCCCCCCHHHHHCC | 28.40 | 23312004 | |
| 38 | Acetylation | ALIGPLGKLMDPGSL HHCCCHHHHCCCCCC | 48.60 | 21543453 | |
| 58 | Ubiquitination | EDLFQDLSHFQETWL HHHHHCHHHHHHHHH | 30.46 | 22505724 | |
| 73 | Phosphorylation | AEAQVPDSDEQFVPD HHCCCCCCCCCCCCC | 36.66 | - | |
| 96 | Sumoylation | HSPTTRIKKEPQSPR CCCCCCCCCCCCCCC | 48.03 | 28112733 | |
| 96 | Acetylation | HSPTTRIKKEPQSPR CCCCCCCCCCCCCCC | 48.03 | 21543453 | |
| 96 | Ubiquitination | HSPTTRIKKEPQSPR CCCCCCCCCCCCCCC | 48.03 | PubMed | |
| 96 | Sumoylation | HSPTTRIKKEPQSPR CCCCCCCCCCCCCCC | 48.03 | - | |
| 97 | Ubiquitination | SPTTRIKKEPQSPRT CCCCCCCCCCCCCCC | 72.72 | 22505724 | |
| 101 | Phosphorylation | RIKKEPQSPRTDPAL CCCCCCCCCCCCCCC | 27.37 | 19307308 | |
| 104 | Phosphorylation | KEPQSPRTDPALSCS CCCCCCCCCCCCCCC | 50.12 | 23312004 | |
| 109 | Phosphorylation | PRTDPALSCSRKPPL CCCCCCCCCCCCCCC | 16.50 | 23312004 | |
| 113 | Acetylation | PALSCSRKPPLPYHH CCCCCCCCCCCCCCC | 34.39 | 21543453 | |
| 139 | Acetylation | PPRQIAIKSPAPGAL CCCEEEEECCCCCCC | 41.17 | 21543453 | |
| 140 | Phosphorylation | PRQIAIKSPAPGALG CCEEEEECCCCCCCC | 21.85 | 25159151 | |
| 149 | Phosphorylation | APGALGQSPLQPFPR CCCCCCCCCCCCCCH | 26.27 | 25159151 | |
| 214 | Phosphorylation | APYQHQLSEPCPPYP CCCCCCCCCCCCCCC | 32.68 | - | |
| 226 | Sumoylation | PYPQQSFKQEYHDPL CCCCCCHHHHHCCHH | 47.68 | - | |
| 226 | Sumoylation | PYPQQSFKQEYHDPL CCCCCCHHHHHCCHH | 47.68 | 25755297 | |
| 226 | Ubiquitination | PYPQQSFKQEYHDPL CCCCCCHHHHHCCHH | 47.68 | PubMed | |
| 260 | Sumoylation | PGAGVVIKQEQTDFA CCCEEEEEECCCCCC | 35.85 | - | |
| 260 | Acetylation | PGAGVVIKQEQTDFA CCCEEEEEECCCCCC | 35.85 | 21543453 | |
| 260 | Sumoylation | PGAGVVIKQEQTDFA CCCEEEEEECCCCCC | 35.85 | - | |
| 260 | Ubiquitination | PGAGVVIKQEQTDFA CCCEEEEEECCCCCC | 35.85 | PubMed | |
| 301 | Acetylation | AMGYGYEKPLRPFPD CCCCCCCCCCCCCCC | 40.65 | 21543453 | |
| 316 | Acetylation | DVCVVPEKFEGDIKQ CEEECCCCCCCCCCC | 42.52 | 21543453 | |
| 322 | Sumoylation | EKFEGDIKQEGVGAF CCCCCCCCCCCCCCH | 47.22 | - | |
| 322 | Sumoylation | EKFEGDIKQEGVGAF CCCCCCCCCCCCCCH | 47.22 | - | |
| 392 | Phosphorylation | KNRPAMNYDKLSRSL CCCCCCCHHHHHHHH | 11.02 | 26657352 | |
| 396 | Phosphorylation | AMNYDKLSRSLRYYY CCCHHHHHHHHHHHH | 26.09 | 26657352 | |
| 398 | Phosphorylation | NYDKLSRSLRYYYEK CHHHHHHHHHHHHHH | 17.52 | 25954137 | |
| 416 | Phosphorylation | QKVAGERYVYKFVCE HHHCCCCEEEEEEEC | 12.11 | - | |
| 441 | Acetylation | DNQRPALKAEFDRPV CCCCCCCCCCCCCCC | 48.23 | 21543453 | |
| 441 | Sumoylation | DNQRPALKAEFDRPV CCCCCCCCCCCCCCC | 48.23 | - | |
| 449 | Phosphorylation | AEFDRPVSEEDTVPL CCCCCCCCHHHCCCH | 37.64 | 23898821 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ETV4_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| HXD4_HUMAN | HOXD4 | physical | 20211142 | |
| A4_HUMAN | APP | physical | 21832049 | |
| STK11_HUMAN | STK11 | physical | 21150337 | |
| STK11_HUMAN | STK11 | physical | 16912160 | |
| JUN_HUMAN | JUN | physical | 16786139 | |
| CARM1_HUMAN | CARM1 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-140 AND SER-149, ANDMASS SPECTROMETRY. | |
| Sumoylation | |
| Reference | PubMed |
| "Extracellular signal-regulated kinase mitogen-activated proteinkinase signaling initiates a dynamic interplay between sumoylation andubiquitination to regulate the activity of the transcriptionalactivator PEA3."; Guo B., Sharrocks A.D.; Mol. Cell. Biol. 29:3204-3218(2009). Cited for: FUNCTION, SUMOYLATION AT LYS-96; LYS-226 AND LYS-260, DESUMOYLATION BYSENP1, UBIQUITINATION BY RNF4, DEUBIQUITINATION BY UPS2, ANDMUTAGENESIS OF LYS-96; GLU-98; SER-101; PRO-102; LYS-226; GLU-228;LYS-260; GLU-262; GLU-324 AND GLU-443. | |